Kataoka S, Kamei T, Ishikawa M, Tsuboi M, Shinzawa H, Goto T, Takahashi T, Ueno K
Gastroenterol Jpn. 1978;13(4):239-43. doi: 10.1007/BF02774046.
Cholecystokinin (CCK)-like activities in the duodenal mucosa were measured by bioassay in patients with duodenal ulcer, cholelithiasis and some other gastrointestinal diseases as well as in healthy normal subjects. The mean CCK-like activity of the duodenal mucosa in patients with duodenal ulcer and cholelithiasis was 0.405 Ivy dog units per milligram and 0.376 Ivy dog units per milligram of dry weight of the duodenal mucosa (IDU/mg d.w.), respectively. Both these figures are significantly higher than 0.180 IDU/mg d.w. in normal subjects (p less than 0.005, p less than 0.005, respectively). It can be speculated that the CCK-level of the duodenal mucosa in patients with cholelithiasis may be regulated by a feedback mechanism and CCK in patients with duodenal ulcer may act physiologically for the cure of duodenal ulcer.
采用生物测定法,对十二指肠溃疡、胆石症及其他一些胃肠道疾病患者以及健康正常受试者十二指肠黏膜中的胆囊收缩素(CCK)样活性进行了测定。十二指肠溃疡患者和胆石症患者十二指肠黏膜的平均CCK样活性分别为每毫克十二指肠黏膜干重0.405 Ivy犬单位和0.376 Ivy犬单位(IDU/mg d.w.)。这两个数值均显著高于正常受试者的0.180 IDU/mg d.w.(分别为p<0.005,p<0.005)。可以推测,胆石症患者十二指肠黏膜的CCK水平可能受反馈机制调节,十二指肠溃疡患者的CCK可能在生理上对十二指肠溃疡的治愈起作用。